These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2858274)

  • 41. NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
    National Toxicology Program, Public Health Services, National Institutes of Health, US Department of Health and Human Services,
    Natl Toxicol Program Tech Rep Ser; 2004 May; (512):7-289. PubMed ID: 15213766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Membrane-associated sialidase of rat liver and its decrease in hepatomas.
    Sagawa J; Miyagi T; Tsuiki S
    Jpn J Cancer Res; 1988 Jan; 79(1):69-73. PubMed ID: 3128507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue array-based expression of transglutaminase-2 in human breast and ovarian cancer.
    Singer CF; Hudelist G; Walter I; Rueckliniger E; Czerwenka K; Kubista E; Huber AV
    Clin Exp Metastasis; 2006; 23(1):33-9. PubMed ID: 16826431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Differing microsomal monoxygenase activity in the cells of ascitic and solid forms of transplantable tumors].
    Kiseleva MG; Belitskiĭ GA
    Biull Eksp Biol Med; 1985 Aug; 100(8):232-4. PubMed ID: 4027374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of type I and type II transglutaminase in normal human bronchial epithelial and lung carcinoma cells.
    Vollberg TM; George MD; Nervi C; Jetten AM
    Am J Respir Cell Mol Biol; 1992 Jul; 7(1):10-8. PubMed ID: 1352692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of tissue transglutaminase by dexamethasone: its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas.
    Johnson TS; Scholfield CI; Parry J; Griffin M
    Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):105-12. PubMed ID: 9512467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Properties of particulate transglutaminase from Yoshida tumor cells.
    Signorini M; Caselli L; Lanzara V; Ferrari C; Melandri P; Bergamini CM
    Biol Chem Hoppe Seyler; 1996 Mar; 377(3):167-73. PubMed ID: 8722318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A monoclonal antibody to cellular transglutaminase.
    Birckbichler PJ; Upchurch HF; Patterson MK; Conway E
    Hybridoma; 1985; 4(2):179-86. PubMed ID: 2861155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Telomerase activity (TMA) in tumour and peritumoural tissues in a rat liver cancer model.
    Zhang HJ; Yang JJ; Tian JM; Wang PJ; Shao CW; Zuo CJ; Zhang SM; Gupta S
    Clin Invest Med; 2009 Feb; 32(1):E8-12. PubMed ID: 19178884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transglutaminase and tumor growth.
    Yancey ST; Laki K
    Ann N Y Acad Sci; 1972 Dec; 202():344-8. PubMed ID: 4629557
    [No Abstract]   [Full Text] [Related]  

  • 52. Liver transglutaminase activity under various experimental conditions.
    WAJDA I; ACS G; CLARKE DD; WAELSCH H
    Biochem Pharmacol; 1963 Mar; 12():241-50. PubMed ID: 13998352
    [No Abstract]   [Full Text] [Related]  

  • 53. Transglutaminase activity in the microfilarial sheath.
    Mehta K; Chandrshekar R
    Parasitol Today; 1995 Jul; 11(7):254; author reply 254. PubMed ID: 15275338
    [No Abstract]   [Full Text] [Related]  

  • 54. The Production of Tumour and Tumour-like Growths in Rats.
    Davis JE
    Can Med Assoc J; 1937 Mar; 36(3):237-41. PubMed ID: 20320551
    [No Abstract]   [Full Text] [Related]  

  • 55. Design of highly active substrates using molecular docking for microbial transglutaminase detection.
    Zou L; Geng X; Li Z; Li T
    RSC Adv; 2023 Feb; 13(8):5259-5265. PubMed ID: 36793302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Central Contribution of TG2 Activity to the Antiproliferative and Pro-Apoptotic Effects of Caffeic Acid in K562 Cells of Human Chronic Myeloid Leukemia.
    Feriotto G; Tagliati F; Brunello A; Beninati S; Tabolacci C; Mischiati C
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structures of Human Transglutaminase 2: Finding Clues for Interference in Cross-linking Mediated Activity.
    Kim GE; Park HH
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evolving Therapy for Celiac Disease.
    Yoosuf S; Makharia GK
    Front Pediatr; 2019; 7():193. PubMed ID: 31157194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer.
    Cellura D; Pickard K; Quaratino S; Parker H; Strefford JC; Thomas GJ; Mitter R; Mirnezami AH; Peake NJ
    Mol Cancer Res; 2015 Jul; 13(7):1095-1105. PubMed ID: 25934693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crystal structure of transglutaminase 2 with GTP complex and amino acid sequence evidence of evolution of GTP binding site.
    Jang TH; Lee DS; Choi K; Jeong EM; Kim IG; Kim YW; Chun JN; Jeon JH; Park HH
    PLoS One; 2014; 9(9):e107005. PubMed ID: 25192068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.